Morphic
formerly Morphic TherapeuticAcquiredWaltham, United States · Founded 2015 · $138.0M raised
- Headquarters
- Waltham, Massachusetts
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- morphictx.com
- Total Funding
- $138.0M
- Last Round
- $80.0M Series BSep 2018
- Rounds
- 3
- Acquisition Date
- Jan 2024
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 5 funding rounds and 9 investors for this company. The full record is or through the API.
About
Morphic develops highly differentiated molecules for autoimmune diseases, fibrotic diseases, and cancer. Its proprietary MInT Platform is used to discover therapeutically relevant small-molecule inhibitors across the integrin family. The company is developing next-generation integrin inhibitors with differentiated selectivity, potency, and pharmacokinetic profiles, and is pursuing additional preclinical programs for pulmonary arterial hypertension and other conditions.
Summary
Morphic is a Biotech company based in Waltham, United States, founded in 2015. It has raised $138.0M in total across 3 rounds, most recently a $80.0M Series B round in Sep 2018. Investors include SR One, Pfizer Ventures and Omega Funds.
Funding & Exit History
2024 (est.)
Sign up to see all 5 events
Funding: Seed through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/morphic"><img src="https://indexed.vc/api/badge/company/morphic" alt="Morphic on Indexed.vc" width="260" height="76" /></a>